Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia.

Meghan C McCormickErika FriehlingRamasubramanian KalpatthiNalyn SiripongKenneth Smith

Published in: Pediatric blood & cancer (2020)

Prophylaxis is cost-effective in preventing bacterial infections in patients with AML. Findings support increased use in patients considered at high risk of bacterial infection secondary to myelosuppression.

Keyphrases

acute myeloid leukemia
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
allogeneic hematopoietic stem cell transplantation
patient reported outcomes
acute lymphoblastic leukemia
young adults